ETAHX
Price
$50.95
Change
-$0.08 (-0.16%)
Updated
Dec 26 closing price
Net Assets
1.71B
JFNIX
Price
$81.75
Change
-$0.19 (-0.23%)
Updated
Dec 26 closing price
Net Assets
5.39B
Interact to see
Advertisement

ETAHX vs JFNIX

Header iconETAHX vs JFNIX Comparison
Open Charts ETAHX vs JFNIXBanner chart's image
Eventide Healthcare & Life Sciences A
Price$50.95
Change-$0.08 (-0.16%)
VolumeN/A
Net Assets1.71B
Janus Henderson Global Life Sciences I
Price$81.75
Change-$0.19 (-0.23%)
VolumeN/A
Net Assets5.39B
ETAHX vs JFNIX Comparison Chart in %
View a ticker or compare two or three
VS
ETAHX vs. JFNIX commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETAHX is a Buy and JFNIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 5.39B vs. ETAHX (1.71B). JFNIX pays higher dividends than ETAHX: JFNIX (0.32) vs ETAHX (0.00). ETAHX was incepted earlier than JFNIX: ETAHX (13 years) vs JFNIX (16 years). ETAHX (1.56) is less costly to investors than JFNIX (0.77). ETAHX is a more actively managed with annual turnover of: 41.00 vs. JFNIX (30.00). ETAHX has a lower initial minimum investment than JFNIX: ETAHX (1000) vs JFNIX (2500). ETAHX annual gain was more profitable for investors over the last year : 54.72 vs. JFNIX (18.56). JFNIX return over 5 years is better than : 17.56 vs. ETAHX (-7.80).
ETAHXJFNIXETAHX / JFNIX
Total Expense Ratio1.560.77203%
Annual Report Gross Expense Ratio1.560.77203%
Fund Existence13 years16 years-
Gain YTD58.23020.734281%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets1.71B5.39B32%
Annual Yield % from dividends0.000.32-
Returns for 1 year54.7218.56295%
Returns for 3 years61.2923.96256%
Returns for 5 years-7.8017.56-44%
Returns for 10 years115.5362.41185%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DSFIY8.130.01
+0.12%
DSM Firmenich AG
GLAPY86.47N/A
N/A
Glanbia Plc
NLGCF0.12N/A
N/A
Northern Lion Gold Corp.
CBLNF29.46N/A
N/A
Mersen
MDNAF0.70N/A
-0.43%
Medicenna Therapeutics Corp.